3FX5 image
Entry Detail
PDB ID:
3FX5
Title:
Structure of HIV-1 Protease in Complex with Potent Inhibitor KNI-272 Determined by High Resolution X-ray Crystallography
Biological Source:
Host Organism:
PDB Version:
Deposition Date:
2009-01-20
Release Date:
2009-03-24
Method Details:
Experimental Method:
Resolution:
0.93 Å
R-Value Free:
0.12
R-Value Work:
0.10
Space Group:
P 21 21 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:protease
Mutations:Q7K, L33I, L63I C67A, C95A
Chain IDs:A, B
Chain Length:99
Number of Molecules:2
Biological Source:Human immunodeficiency virus 1
Peptide-like Molecules
PRD_000562
Primary Citation
Structure of HIV-1 protease in complex with potent inhibitor KNI-272 determined by high-resolution X-ray and neutron crystallography.
Proc.Natl.Acad.Sci.USA ? ? ? (2009)
PMID: 19273847 DOI: 10.1073/pnas.0809400106

Abstact

HIV-1 protease is a dimeric aspartic protease that plays an essential role in viral replication. To further understand the catalytic mechanism and inhibitor recognition of HIV-1 protease, we need to determine the locations of key hydrogen atoms in the catalytic aspartates Asp-25 and Asp-125. The structure of HIV-1 protease in complex with transition-state analog KNI-272 was determined by combined neutron crystallography at 1.9-A resolution and X-ray crystallography at 1.4-A resolution. The resulting structural data show that the catalytic residue Asp-25 is protonated and that Asp-125 (the catalytic residue from the corresponding diad-related molecule) is deprotonated. The proton on Asp-25 makes a hydrogen bond with the carbonyl group of the allophenylnorstatine (Apns) group in KNI-272. The deprotonated Asp-125 bonds to the hydroxyl proton of Apns. The results provide direct experimental evidence for proposed aspects of the catalytic mechanism of HIV-1 protease and can therefore contribute substantially to the development of specific inhibitors for therapeutic application.

Legend

Protein

Chemical

Disease

Primary Citation of related structures